Macular dystrophies: clinical and imaging features, molecular genetics and therapeutic options.
Ontology highlight
ABSTRACT: Macular dystrophies (MDs) consist of a heterogeneous group of disorders that are characterised by bilateral symmetrical central visual loss. Advances in genetic testing over the last decade have led to improved knowledge of the underlying molecular basis. The developments in high-resolution multimodal retinal imaging have also transformed our ability to make accurate and more timely diagnoses and more sensitive quantitative assessment of disease progression, and allowed the design of optimised clinical trial endpoints for novel therapeutic interventions. The aim of this review was to provide an update on MDs, including Stargardt disease, Best disease, X-linked r etinoschisis, pattern dystrophy, Sorsby fundus dystrophy and autosomal dominant drusen. It highlights the range of innovations in
SUBMITTER: Rahman N
PROVIDER: S-EPMC7147237 | biostudies-literature | 2020 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA